Docetaxel in Combination with Nivolumab or Placebo
Español  |  中國傳統的  |  简体中文
Call us  (855) 528-7322
Main Menu

Docetaxel in Combination with Nivolumab or Placebo

Sponsor: Bristol-Myers Squibb

Protocol CA209-7DX: A Phase 2, Randomized Study of Nivolumab or Placebo in Combination with Docetaxel in Men with Metastatic Castration-resistant Prostate Cancer.